The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2022 | How COVID-19 has impacted clinical practice and treatment approaches in multiple myeloma
Meera Mohan, MD, MS, FACP, Medical college of Wisconsin, Milwaukee, WI, briefly discusses how COVID-19 has impacted treatment approaches and clinical practice in multiple myeloma (MM). In general, the approach to treatment has changed, with more virtual visits taking place. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
GSK: Research Funding; BMS/Celgene: Research Funding; Takeda: Research Funding; Novartis: Research Funding.
